Impact 20-2020-Omada
Courtesy of OmadaCourtesy of Omada

    Omada Health provides digital care with a human touch for chronic diseases such as heart disease and hypertension. Omada pairs its participants with live coaches via its telehealth platform, enabling medical-care providers to increase their reach while keeping costs down. As the largest CDC-recognized provider taking part in the National Diabetes Prevention Program, Omada works with Medicaid programs, community health centers and others to help over 350,000 at-risk participants prevent the onset of Type 2 diabetes. Recently Omada acquired Physera for $30 million, adding physical therapy to its portfolio of digital care programs for common high-cost conditions. Omada is not only a leader in tech and machine learning–the San Francisco-based company has published 14 peer-reviewed studies overall demonstrating the effectiveness of its work. Omada reports a valuation of $600 million and has raised over $250 million; its backers include the venture arms of healthcare providers, including Cigna Ventures and Kaiser Permanente Ventures.

    Company information

    HeadquartersSan Francisco
    CEOSean Duffy
    No. of employees (approximate)500
    InvestorsAndreessen Horowitz, Norwest Venture Partners, U.S. Venture Partners, Cigna Ventures, Kaiser Permanente Ventures